Skip to content

Can 15 minutes of whole body vibration therapy improve muscle and bone health in children and adolescents with cerebral palsy?

The effects of 15 minutes whole body vibration therapy on muscle function and bone density in children and adolescents with cerebral palsy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000145505
Enrollment
17
Registered
2015-02-17
Start date
2015-02-05
Completion date
2019-03-28
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Cerebral palsy (CP) is the most common disability in childhood. CP is characterized by reduced muscle mass, impaired mobility and low bone density. Therefore, one of the major focuses of therapy in CP children is to increase muscle mass and power, thereby increasing mobility, weight bearing and bone health. Unfortunetely, there is a void in therapeutic interventions aimed at increasing muscle mass, muscle function as well as bone mass in CP children. Whole body vibration training (WBVT) has the potential to fill this therapeutic void. WBVT studies in healthy adults and postmenopausal females have been shown to enhance muscle function and bone health. However, it is unclear whether children with CP would benefit from WBVT. Most studies have used 9 minutes of therapy per session. We aim to look at the impact of prolonged use (15 minutes) of vibration on muscle and bones. By maintaining muscle mass and bone mineral accrual during growth; WBVT can maximize mobility and bone strenght into adult life improving both mobility and quality of life. The proposed study aims to determine the effect of 20 weeks of WBVT on muscle and bone in children with CP by doing it for 15 minutes four times a week instead of the 9 minutes used in previous studies. This should lead to improved health and well-being of adolescents with CP.

Interventions

Participants in the study will perform whole body vibration therapy (WBVT) four times a week for 20 weeks. Each training session consists of five 3 minute WBVT with three minute rest breaks between each WBVT. Participants will weight bear (stand with or without aid) on a vibration plate that moves rapidly ( 12-22Hz) up and down over a small distance ( up to 10 mm) generating vibration stimulus. The vibration causes the muscle in the leg and trunk to contract. Sessions will be perform at home or

Participants in the study will perform whole body vibration therapy (WBVT) four times a week for 20 weeks. Each training session consists of five 3 minute WBVT with three minute rest breaks between each WBVT. Participants will weight bear (stand with or without aid) on a vibration plate that moves rapidly ( 12-22Hz) up and down over a small distance ( up to 10 mm) generating vibration stimulus. The vibration causes the muscle in the leg and trunk to contract. Sessions will be perform at home or local school and will be supervised by an experienced physiotherapist. Each participant will have a training diary to log all sessions performed and the time/ intensity used. The diary will help to monitor the participants adherence to the training programme.

Sponsors

Prof Paul Hofman
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
8 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

Adolescents with cerebral palsy (GMFCS II-IV) aged between 8-20 years. To be included in the study participants must be able to stand on the vibration plate ( with or without assistance) and be able to undertake evaluation assessments

Exclusion criteria

Participants will be excluded if:1)They have a fracture within 8 weeks of enrolment, pregnancy and acute thrombosis, muscle or tendon inflammation, renal stones, discopathy or arthritis. 2) There is a history of clinically significant organic disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study. 3)There is a history of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrolment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone. Participants will not receive Botulinium toxin injection throughout duration of the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026